Sumatriptan 50mg, available through our PGD service, is tailored for those suffering from intense migraine discomfort. By targeting blood vessel swelling in the brain, a key migraine trigger, it offers reliable relief, as confirmed by clinical studies. Access to this medication requires a pharmacist consultation via our service to ensure its safety and suitability for your specific needs.

Key Features

Primary Function: The main role of Teva Sumatriptan 50mg lies in addressing migraine headaches and their related discomforts.
Effective and Fast-Acting: Known for swift relief, the medication starts working within 30 to 120 minutes after intake.
MHRA Approved: With MHRA endorsement, Sumatriptan assures both safety and effectiveness.
Affordable: The price of Sumatriptan has become more budget-friendly compared to its initial market introduction.
Widely Available: Sumatriptan is accessible in numerous countries, spanning high-income to middle- and low-income regions.

What symptoms or conditions can be treated with Teva Sumatriptan 50mg?

Teva Sumatriptan 50mg targets migraine headaches and associated symptoms such as nausea and light and sound sensitivity.

What are the benefits of using Teva Sumatriptan 50mg?

This medication ensures prompt and efficient mitigation of migraine symptoms, aiding individuals in resuming their everyday activities.

How does Teva Sumatriptan 50mg work?

Teva Sumatriptan 50mg operates by contracting blood vessels around the brain and reducing elements that can provoke headaches and other migraine indicators.

Are there any known side effects?

Some individuals might encounter temporary side effects like dyspepsia, nausea, drowsiness, and dizziness.

Is Sumatriptan safe to use during pregnancy and breastfeeding?

Evidence suggests that Sumatriptan does not significantly raise the risk of birth defects during pregnancy. However, it must be prescribed by a doctor for use in pregnancy or breastfeeding.

What is the onset of action for this medication?

The action of Sumatriptan begins between 30 to 120 minutes, offering expedited relief from migraine symptoms

Patient information leaflet

Ingredients

Active ingredient: Sumatriptan succinate 50mg

Tablet core: lactose monohydrate, croscarmellose sodium, colloidal anhydrous silica, microcrystalline cellulose, magnesium stearate.
Film coating: hypromellose, lactose monohydrate, titanium dioxide (E171), macrogol 3000, glycerol triacetate; 50 mg tablets also have iron oxides red, yellow, black (E172).

Usage and Instructions

Take 1 dose at migraine onset. If symptoms return, a second dose can be taken after 2 hours, but no more than 2 doses in 24 hours. Don't take a second dose if the first doesn't work, but you may use paracetamol, aspirin, or NSAIDs for relief.

Warnings

Use Sumatriptan only if your migraine has been diagnosed.
It's not for all migraine types like hemiplegic or basilar.
If experiencing unusual symptoms, check for other conditions.
There's a slight risk of stroke or heart issues.
Chest discomfort after taking needs checking.
Combining with certain antidepressants can lead to rare reactions.
Be cautious if you have high blood pressure or liver issues.
Sumatriptan and St John's Wort together might increase side effects.
Overusing headache medicines could make headaches worse.
Stick to the recommended dose.
Those with heart risks need a check-up first.

Please avoid using Sumatriptan if you:

Are allergic to sumatriptan or any ingredients in the medication.
Have heart issues, including ischaemic heart disease, angina, or previous heart attacks.
Suffer from peripheral vascular disease.
Have had a stroke or transient ischaemic attack (TIA).
Have high blood pressure, unless it's mild and treated.
Have severe liver disease.
Are using other migraine treatments, ergotamine, methysergide, other triptans, or 5HT1 agonists.
Are taking MAOIs (within 2 weeks), SSRIs (e.g., citalopram, fluoxetine), or SNRIs (e.g., venlafaxine).

Side Effects

System Disorder Category	Frequency	Details
Immune System Disorders	Not known	Reactions from skin hypersensitivity to anaphylaxis.
Nervous System Disorders	Common	Dizziness, drowsiness, sensory disturbances.
	Not known	Seizures, tremor, dystonia, nystagmus, scotoma.
Eye Disorders	Not known	Flickering, diplopia, reduced vision, permanent vision loss possible.
Cardiac Disorders	Not known	Bradycardia, tachycardia, palpitations, arrhythmias, ischaemic changes, coronary vasospasm, angina, myocardial infarction.
Vascular Disorders	Common	Transient blood pressure increases, flushing.
	Not known	Hypotension, Raynaud's phenomenon.
Respiratory, Thoracic, Mediastinal Disorders	Common	Dyspnoea.
Gastrointestinal Disorders	Common	Nausea and vomiting.
	Not known	Ischaemic colitis, diarrhoea, dysphagia.
Musculoskeletal, Connective Tissue Disorders	Common	Sensations of heaviness, myalgia.
	Not known	Neck stiffness, arthralgia.
General Disorders and Administration Site Conditions	Common	Pain, heat/cold sensations, pressure/tightness, weakness, fatigue.
Investigations	Very rare	Minor liver function test disturbances.
Psychiatric Disorders	Not known	Anxiety.
Skin and Subcutaneous Tissue Disorders	Not known	Hyperhidrosis.